Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.
Publication
, Journal Article
Ciafaloni, E; Massey, JM; Tucker-Lipscomb, B; Sanders, DB
Published in: Neurology
January 9, 2001
In an open-label study, 12 patients with refractory MG or who were taking only corticosteroids and required additional immunosuppression received mycophenolate mofetil 1 g twice daily for 6 months. A reduction of three points in a quantified MG score and two points in a manual muscle test or a reduction of 50% in corticosteroid dose defined efficacy. Eight patients improved, beginning after 2 weeks to 2 months. No major side effects were observed.
Duke Scholars
Published In
Neurology
DOI
ISSN
0028-3878
Publication Date
January 9, 2001
Volume
56
Issue
1
Start / End Page
97 / 99
Location
United States
Related Subject Headings
- Treatment Outcome
- Pilot Projects
- Neurology & Neurosurgery
- Mycophenolic Acid
- Myasthenia Gravis
- Middle Aged
- Male
- Immunosuppressive Agents
- Humans
- Female
Citation
APA
Chicago
ICMJE
MLA
NLM
Ciafaloni, E., Massey, J. M., Tucker-Lipscomb, B., & Sanders, D. B. (2001). Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology, 56(1), 97–99. https://doi.org/10.1212/wnl.56.1.97
Ciafaloni, E., J. M. Massey, B. Tucker-Lipscomb, and D. B. Sanders. “Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.” Neurology 56, no. 1 (January 9, 2001): 97–99. https://doi.org/10.1212/wnl.56.1.97.
Ciafaloni E, Massey JM, Tucker-Lipscomb B, Sanders DB. Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology. 2001 Jan 9;56(1):97–9.
Ciafaloni, E., et al. “Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.” Neurology, vol. 56, no. 1, Jan. 2001, pp. 97–99. Pubmed, doi:10.1212/wnl.56.1.97.
Ciafaloni E, Massey JM, Tucker-Lipscomb B, Sanders DB. Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology. 2001 Jan 9;56(1):97–99.
Published In
Neurology
DOI
ISSN
0028-3878
Publication Date
January 9, 2001
Volume
56
Issue
1
Start / End Page
97 / 99
Location
United States
Related Subject Headings
- Treatment Outcome
- Pilot Projects
- Neurology & Neurosurgery
- Mycophenolic Acid
- Myasthenia Gravis
- Middle Aged
- Male
- Immunosuppressive Agents
- Humans
- Female